Authors: Ashish K. Khanna, M.D., FCCP, FCCM et al ASA Monitor May 2019, Vol. 83, 18–20. Historical Perspective More than 65 years ago, Dr. Bjorn Ibsen, a Copenhagen anesthesiologist, was savvy enough to recognize the need to create the first ICU – the stimulus for which was the polio epidemic of 1952-53. At that time, over […]
Read MoreAuthors: Adjoa Boateng, MD, MPH; Vivek K. Moitra, MD, MHA, FCCM ASA Monitor October 2021, Vol. 85, 38–40. While critical care medicine has been a recognized and valuable subspeciality of anesthesiology for many years and the scope of practice has expanded, in many respects the recent COVID-19 pandemic has accelerated its transformation. Until recently, and for many […]
Read MoreAuthors: David J. Douin, M.D.; Ana Fernandez-Bustamante, M.D., Ph.D. Editorial Anesthesiology July 2022, Vol. 137, 13–14. “[What is] the potential value of hypercoagulability assays in the management of patients with hypoxemia and ARDS?” Image: J. P. Rathmell The presence of coagulation abnormalities in acute respiratory distress syndrome (ARDS) has been identified and studied for decades and these investigations […]
Read MoreAuthor: Stuart A. Forman, M.D., Ph.D. Anesthesiology June 2022, Vol. 136, 880–882. Midazolam is a benzodiazepine that at low doses is widely used in periprocedural care settings to assure amnesia and produce anxiolysis and sedation, while high doses are less frequently used to induce hypnosis (unconsciousness). Midazolam is also used to acutely suppress seizures. The molecular […]
Read MoreAuthors: Sharon C. Reale, M.D. et al Anesthesiology May 2022, Vol. 136, 697–708. Background Estimates for the incidence of difficult intubation in the obstetric population vary widely, although previous studies reporting rates of difficult intubation in obstetrics are older and limited by smaller samples. The goals of this study were to provide a contemporary estimate of […]
Read More